Veterinary Medicines

TAbic V.H., šnypščioji tabletė vištoms ir kalakutams

Authorised
  • Newcastle disease virus, strain V.H., Live
Download as PDF

Product identification

Medicine name:
TAbic V.H., šnypščioji tabletė vištoms ir kalakutams
Active substance:
  • Newcastle disease virus, strain V.H., Live
Target species:
  • Chicken
  • Turkey
Route of administration:
  • In drinking water use
  • Ocular use
  • Nebulisation use

Product details

Active substance and strength:
  • Newcastle disease virus, strain V.H., Live
    1000000.00
    50% Embryo Infective Dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Effervescent tablet
Withdrawal period by route of administration:
  • In drinking water use
    • Chicken
      • Meat and offal
        0
        day
    • Turkey
      • Meat and offal
        0
        day
  • Ocular use
    • Chicken
      • Meat and offal
        0
        day
    • Turkey
      • Meat and offal
        0
        day
  • Nebulisation use
    • Chicken
      • Meat and offal
        0
        day
    • Turkey
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Phibro Animal Health (Poland) Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Synoptis Industrial Sp. z o.o.
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/08/1827/001-014
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Lithuanian (PDF)
Published on: 10/06/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."